Efficacy of inosine pranobex in frequently ill children with chronic Epstein–Barr virus infection: randomized study

Efficacy of inosine pranobex in frequently ill children with chronic Epstein–Barr virus infection: randomized study

Show other versions (1)

<p><em>High incidence of acute respiratory infections (ARI) in immunocompromised frequently ill children with chronic Epstein–Barr infection forces the prescription of drugs with complex antivirus and immunocorrecting effect. The objective: to study the efficacy of inosine pranobex (Isop...

Full description

Bibliographic Details
Main Authors:	E.N. Simovanyan, V.B. Denisenko, A.V. Grigoryan
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2011-01-01
Series:	Вопросы современной педиатрии
Online Access:	http://vsp.spr-journal.ru:80/jour/article/view/562

Similar Items

Efficacy of inosine pranobex in frequently ill children with chronic Epstein–Barr virus infection: randomized study
by: E.N. Simovanyan, et al.
Published: (2011-03-01)

The Effectiveness of Complex Use of Inosine Pranobex and Recombinant Interferon-
by: E. N. Simovanyan, et al.
Published: (2015-12-01)

Use of inosine pranobex in frequently ill children
by: V. N. Drozdov, et al.
Published: (2019-11-01)

Genotoxicity and mutagenicity of inosine pranobex
by: Tobólska Sylwia, et al.
Published: (2018-07-01)

Human papillomavirus infection: the efficacy of treatment with inosine pranobex
by: P V Budanov, et al.
Published: (2015-12-01)

Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes
by: Lasek Witold, et al.
Published: (2015-06-01)

ROLE OF INOSINE PRANOBEX IN MANAGEMENT OF HPV-ASSOCIATED DISEASES: PROBLEMS AND PROSPECTIVE
by: V. O. Bitsadze, et al.
Published: (2016-10-01)

Epstein-Barr Virus Infection in Children: Improving the Diagnosis and Treatment Program
by: E. N. Simovanyan, et al.
Published: (2016-04-01)

Efficacy of inosine pranobex as an adjuvant oral therapy in anogenital warts: an evidence-based case report
by: Benny Nelson, et al.
Published: (2019-06-01)

Evaluation of the influence of Inosine pranobex on the matrix protein system in patients with chronic viral cervicitis
by: T. A. Nevezhkina, et al.
Published: (2023-06-01)

Influence of inosine pranobex on cell viability in normal fibroblasts and liver cancer cells
by: Tobólska Sylwia, et al.
Published: (2018-07-01)

Effect of inosine pranobex on p16, Ki-67 expression in patients with HPV-associated cervical intraepithelial neoplasia
by: T V Klinyshkova, et al.
Published: (2018-08-01)

Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course
by: Jiří Beran, et al.
Published: (2021-11-01)

Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression
by: McCarthy, M, et al.
Published: (2019)

Pathogenesis of formation of frequent respiratory infections in children with Epstein-Barr virus and cytomegalovirus infection
by: I. V. Babachenko, et al.
Published: (2014-09-01)

Epstein-Barr virus reactivation in critically ill immunocompetent patients
by: Nicolas Libert, et al.
Published: (2015-02-01)

RISK FACTORS OF OPPORTUNISTIC INFECTIONS IN CHILDREN WITH PARENTERAL HIV INFECTION
by: V.B. Denisenko, et al.
Published: (2011-01-01)

RISK FACTORS OF OPPORTUNISTIC INFECTIONS IN CHILDREN WITH PARENTERAL HIV INFECTION
by: V.B. Denisenko, et al.
Published: (2011-05-01)

Epstein–Barr virus and multiple sclerosis
by: A. I. Skliar, et al.
Published: (2020-12-01)

Infection with Epstein-Barr virus.
by: Warrell, D, et al.
Published: (1978)

Infection with Epstein-Barr virus.
by: Warrell, D, et al.
Published: (1978)

Resurrecting Epstein–Barr Virus
by: Roberto Paganelli
Published: (2022-07-01)

??????? ??? ????? ????? ???????- ???Epstein-Barr virus(EBV) ????? ?????? ????? ????? ?? ?????? ?? ???
by: ستار عبود فارس, et al.
Published: (2019-05-01)

??????? ??? ????? ????? ???????- ???Epstein-Barr virus(EBV) ????? ?????? ????? ????? ?? ?????? ?? ???
by: ستار عبود فارس, et al.
Published: (2019-05-01)

Epstein-Barr virus and skin
by: Martin Sangueza-Acosta, et al.
Published: (2018-12-01)

Epidemiological characteristics of Epstein–Barr virus infection
by: T. V. Solomay, et al.
Published: (2022-01-01)

Frequency of Epstein - Barr Virus in Patients Presenting with Acute Febrile Illness in Kenya.
by: Clement Masakhwe, et al.
Published: (2016-01-01)

Inosine Pranobex Significantly Decreased the Case-Fatality Rate among PCR Positive Elderly with SARS-CoV-2 at Three Nursing Homes in the Czech Republic
by: Jiří Beran, et al.
Published: (2020-12-01)

Frequent co-reactivation of Epstein–Barr virus in patients with cytomegalovirus viremia under immunosuppressive therapy and/or chemotherapy
by: Yuki Hatayama, et al.
Published: (2020-11-01)

Seasonality of infection caused by Epstein – Barr virus
by: T. V. Solomay, et al.
Published: (2020-10-01)

Soro-epidemiologia do virus de Epstein-Barr (VEB) The seroepidemiology of the Epstein-Barr vírus (EBV)
by: Claudio Sergio Pannuti
Published: (1981-02-01)

Vaccination against the Epstein-Barr virus
by: Rühl, J, et al.
Published: (2020)

The epstein-Barr virus and the pathogenesis of lymphoma
by: Vockerodt, M., et al.
Published: (2015)

Epstein-barr virus specific immunogen
by: Seow, Heng Fong, et al.
Published: (2011)

The pathology of epstein-barr virus lymphoproliferations
by: Stefan D. Dojcinov, et al.
Published: (2019-06-01)

Epstein–Barr Virus Infection in Cancer
by: Lucia Mundo, et al.
Published: (2023-09-01)

Epstein–Barr Virus History and Pathogenesis
by: Hui Yu, et al.
Published: (2023-03-01)

Epstein-Barr Virus in Gastric Carcinoma
by: Jun Nishikawa, et al.
Published: (2014-11-01)

Epstein-Barr Virus and Neurological Diseases
by: Nan Zhang, et al.
Published: (2022-01-01)

Novel Therapeutics for Epstein–Barr Virus
by: Graciela Andrei, et al.
Published: (2019-03-01)